{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:16:25Z","timestamp":1795108585109,"version":"4.10.3"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100605","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:07:32Z","timestamp":1783782452000},"page":"100605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhanced intracellular delivery and antifungal potency of amphotericin\u00a0B via PEG15HS-lipid nanoparticles"],"prefix":"10.1016","volume":"12","author":[{"given":"K\u00e9vin","family":"Brunet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Baillod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Clarhaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Tewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100605_bb0005","author":"Ali"},{"key":"10.1016\/j.ijpx.2026.100605_bb0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2007.04.027","article-title":"Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion","volume":"344","author":"Anton","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100605_bb0015","series-title":"EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.2.","author":"Arendrup","year":"2020"},{"key":"10.1016\/j.ijpx.2026.100605_bb0020","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/AAC.36.10.2310","article-title":"Effects of the aggregation state of amphotericin B on its toxicity to mice","volume":"36","author":"Barwicz","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpx.2026.100605_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/jof8020121","article-title":"Improved in Vitro Anti-Mucorales activity and Cytotoxicity of Amphotericin B with a Pegylated Surfactant","volume":"8","author":"Brunet","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijpx.2026.100605_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/jof6040321","article-title":"Amphotericin B and Other Polyenes\u2014Discovery, Clinical Use, Mode of Action and Drug resistance","volume":"6","author":"Carolus","year":"2020","journal-title":"Journal of Fungi"},{"key":"10.1016\/j.ijpx.2026.100605_bb0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jconrel.2023.09.031","article-title":"Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA","volume":"363","author":"Friis","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100605_bb0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpx.2026.100605_bb0045","first-page":"1313","article-title":"Microencapsulation of nanoemulsions: novel Trojan particles for bioactive lipid molecule delivery","volume":"6","author":"Li","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100605_bb0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpx.2026.100605_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2013.03.054","article-title":"Lipid-based formulations for oral administration of poorly water-soluble drugs","volume":"453","author":"Mu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100605_bb0060","author":"Polyoxyl 15 Hydroxystearate UNII 71YMM1X75O"},{"key":"10.1016\/j.ijpx.2026.100605_bb0065","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpx.2026.100605_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/mmy.38.3.201.207","article-title":"Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS","volume":"38","author":"Rodero","year":"2000","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ijpx.2026.100605_bb0075","first-page":"1","article-title":"Formulation des micro-\u00e9mulsions par la m\u00e9thode HLD","author":"Salager","year":"2001","journal-title":"Techniques de l\u2019Ing\u00e9nieur"},{"key":"10.1016\/j.ijpx.2026.100605_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/EBC20160058","article-title":"Antibiotic-non-antibiotic combinations for combating extremely drug-resistant Gram-negative \u201csuperbugs.\u201d","volume":"61","author":"Schneider","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ijpx.2026.100605_bb0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0005-2736(90)90305-8","article-title":"The effect of surfactants on the aggregation state of amphotericin B","volume":"1030","author":"Tancr\u00e9de","year":"1990","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"10.1016\/j.ijpx.2026.100605_bb0090","author":"US FDA"},{"key":"10.1016\/j.ijpx.2026.100605_bb0095","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3390\/pharmaceutics13111849","article-title":"Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. Coli MCR-1 to Colistin","volume":"13","author":"Valcourt","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100605_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02383-17","article-title":"The viscoelastic properties of the fungal cell wall allow traffic of AmBisome as intact liposome vesicles","volume":"9","author":"Walker","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.ijpx.2026.100605_bb0105","author":"WHO"},{"key":"10.1016\/j.ijpx.2026.100605_bb0110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/1381612822666151209151719","article-title":"Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index","volume":"22","author":"Zia","year":"2016","journal-title":"Curr. Pharm. Des."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:18:25Z","timestamp":1795105105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":22,"alternative-id":["S2590156726001258"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100605","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced intracellular delivery and antifungal potency of amphotericin\u00a0B via PEG15HS-lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100605"}}